SMS Pharmaceuticals Ltd (BOM:532815)
₹ 245.75 1.2 (0.49%) Market Cap: 20.80 Bil Enterprise Value: 23.22 Bil PE Ratio: 41.65 PB Ratio: 3.88 GF Score: 87/100

Q4 2024 SMS Pharmaceuticals Ltd Earnings Call Transcript

May 31, 2024 / 05:30AM GMT
Release Date Price: ₹197.95 (-6.34%)
Operator

Ladies and gentlemen, good and welcome to the SMS Pharmaceuticals Limited Q4 FY24 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectation of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict as a reminder, all participants' lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. If you do need assistance during the conference call, please signal an operator by pressing star, then zero on your touchtone phone. Please note that this conference is being recorded today. We have with us Mr. from SEEK rationale, but newly executed Director, Mr. Lakshmi Narayana community Chief Financial Officer. I now hand the conference over to Mr. Clancy, Krishna, but Moody's a schedule Director.

Thank you. And over to you, sir.

Vamsi Potluri
SMS Pharmaceuticals Ltd - Executive Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot